Home News Alkem Laboratories’ arm Enzene Biosciences receives 6 US FDA observations, no data... News Alkem Laboratories’ arm Enzene Biosciences receives 6 US FDA observations, no data integrity issues February 16, 2026 FacebookTwitterPinterestWhatsAppLinkedin Shares of Alkem Laboratories Ltd ended at ₹5,475.55, up by ₹74.00, or 1.37%, on the BSE.Read More RELATED ARTICLESMORE FROM AUTHOR News Goyal urges industry to raise quality standards to achieve $2 trillion export target News PM Narendra Modi to inaugurate Noida International Airport in March, says Yogi Adityanath AI AI startup Emergent scales at record speed by letting anyone build apps on their phone 13,000FansLike9,000FollowersFollowMost PopularAll AllFeaturedAll time popular GMDC Q3 Results: Net profit falls 10% to ₹133 crore, revenue... News February 13, 2026 Mumbai Society Pays Rs 2.5 Lakh/Yr To Owners, Instead Of Charging... Uncategorized February 10, 2026 Indians Won’t Be Getting Any H1B Visa In 2026 Uncategorized January 28, 2026 Daily Indian Funding Roundup & Key News – 3rd February 2026:... Uncategorized February 3, 2026 Capgemini Sells US Subsidiary For Govt Contracts Uncategorized February 3, 2026
